Erectile dysfunction (ED) is a common medical condition that affects the sexual life of millions of men worldwide. Numerous physical and psychological factors are involved in normal erectile function, including neurological, vascular, hormonal and cavernous functions. The current therapy for the condition is pharmacological and psychotherapeutic which regulates the erectile function and amplifies the NO-mediated response. The aim of this work is to test the action of three common phosphodiesterase inhibitors: Tadalafil, Sildenafil Citrate and Vardenafil at 0.05 μM on human monocytes, analyzing the expression of iNOS protein and mRNA by Western blot and rt-PCR, and production of NO by conversion of L-(2,3,4,5)-[3H]Arginine to L-(3H) citrulline. We also tested the efficiency of the antioxidant network by spectrophotometer (SOD, CAT, GPx and Gr), under normal conditions and after stimulation with LPS. The results showed an increase in ROS levels, similar for all the molecules with regard to the antioxidant enzymes. In all cases the treatment determines a response to the limited efficiency, arriving at a situation in which phosphodiesterase inhibitors + LPS clearly show oxidative stress.
NIH Consensus Development Panel on Impotence. Impotence: NIH Consensus Conference1993; JAMA270:83–90.
2.
AytacIAMcKinlayJBKraneRJ. The likely worldwide increase in erectile dysfunction between 1995 and 2025 and possible policy consequences. BJU Int1999; 84:50–56.
3.
SpectorIPCareyMP. Incidence and prevalence of the sexual dysfunction: A critical review of the empirical literature. Arch Sex Behav1990; 19:389–408.
4.
MelmanAGingellCJ. The epidemiology and pathophysiology of erectile disfunction. J Urology1999; 161:5–11.
5.
GiulianoFAllardJ. Apomorphine SL (Uprima®): Preclinical and clinical experience learned from the first central nervous system-acting ED drug. Int J Impot Res2002; 14(1):S53–6.
6.
Dula E, Bukofzer S, Perdok R, George M, Apomorphine SL Study Group. Double-blind, crossover comparison of 3 mg apomorphine SL whith placebo and whith 4 mg apomorphine SL in male erectile dysfunction. Eur Urol2001; 39:558–64.
7.
BukofzerSLiveseyN. Safety and tolerability of apomorphine SL (Uprima®). Int Impot Res2001; 13(3):S40–4.
8.
UckertSKutheAStiefCGJonasU. Phosphodiesterase isoenzymes as pharmacological targets in the treatment of male erectile dysfunction. World J Urol2001; 19:14–22.
9.
Padma-NathanHEardleyIKlonerRALatiesAMMontorsiF. A 4-year update on the safety of sildenafil citrate (Viagra®). Urology2002; 60(SB):67–90.
10.
MoralesAGingellCCollinsMWickerPAOsterlohIH. Clinical safety of oral sildenafil citrate (Viagra®) in the treatment of erectile dysfunction. Int J Impot Res1998; 10:69–74.
11.
StarkSSachseRLiedlTHensenJRohdeGWensingGHorstmannRSchrottKM. Vardenafil increases penile rigidity and tumescence in men with erectile dysfunction after a single dose. Eur Urol2001; 40:181–90.
12.
GadauMFernandezACuevasPMartinsTAnguloJ. Tadalafil (IC351) enhances NO-mediated relaxation of human arterial and trabeculare penile smooth muscle. Int J Impot Res2001; 13(S4):14.
13.
JuilfsDHSoderlingSBurnsFBeavoJA. Cyclic GMP as substrate and regulator of cyclic nucleotide phosphodiesterase (PDE5). Rev Physiol Biochem Pharmacol1999; 135:67–104.
14.
RajferJAronsonWJBushPADoreyFJIgnarroLJ. Nitric oxide as a mediator of relaxation of the corpus cavernosum in response to nonadrenergic, noncholinergic neurotransmission. N Engl J Med1992; 326:90–94.
15.
BonominiMPandolfiADi PietroN. Adherence of uremic erytrocytes to vascular endothelium decreases endothelial nitric oxide synthase expression. Kidney Int2005; 65:1899–906.
16.
GrilliADe LutiisMAPatrunoA. Effect of chronic hypoxia on inducile nitric oxide synthase expression in rat myocardial tissue. Exp Biol Med2003; 228:935–42.
17.
RealeMDe LutiisMAPatrunoA. Modulation of MCP-1 and iNOS by 50 –Hz sinusoidal electromagnetic field. Nitric Oxide2006; 15:50–7.
SunMZigmanS. An improved spectrophotometric assay for superoxide dismutase based on epinephrine autoxidation. Anal Biochem1978; 90:81–9.
20.
AebiHE. Catalase. In: Bergamaier HU eds Methods in enzymatic analysis, Verlag Chemie, Weinheim1974; 2:673–84.
21.
PagliaDEValentineWN. Studies on the qualitative and quantitative characterization of erythrocytes glutathione peroxidase. J Lab Clin Med1967; 70:158–69.
22.
Di IlioCSacchettaPLo BelloMCaccuriGFedericiG. Selenium independent glutathione peroxidase activity associated with cationic forms of glutathione transferase in human hearth. J Mol Cell Cardiol1986; 18:983–91.
23.
AmicarelliFRagnelliAMAimolaPBonfigliAColafarinaSDi IlioCMirandaM. Age-dependent ultrastructural alterations and biochemical response of rat skeletal muscle after hypoxic or hyperoxic treatments. Biochim Biophys Acta1999; 1453(1):105–14.
24.
AversaABruzzichesRVitaleCMarazziGFrancomanoDBarbaroGSperaGRosanoGM. Chronic Sildenafil in men with diabete san erectile dysfunction. Exper Opin Drug Metab Toxicol2007; 3:41–64.
25.
NevratilP. Erectile dysfunction, its relation to diabetes its management 2007. Vinitr Lek2008; 54:485–7.
26.
StuckeyBGWalshJPChingHLStcukeyAWPalmerNRThomposonPLWattsGF. Erectile dysfunction predicts generalised cardiovascular diseases: Evidence from a case- control study. Atherosclerosis2007; 194:458–64.
AndersonKEWagnerG. Physiology of penile erection. Physiol Rev1995; 75:191–236.
29.
KraneRJGoldsteinIde TejadaI Saenz. Impotence. N Engl J Med1989; 321:1648–59.
30.
de TejadaI Saenz. Molecular mechanisms for the regulation of penile smooth muscle contractility. Int J Impot Res2002; 14(S):S6–10.
31.
AdaikanPGNgSC. Physiological significance of nitrergic transmission in human penile erection. Asian. J Androl2000; 2:51–6.
32.
TodaNAvajikiKOkamuraT. Nitric oxide and penile erectile function. Pharmacol Ther2005; 106:233–66.
33.
BlancoRde TejadaI SaenzGoldsteinI. Cholinergic neurotransmission in human corpus cavernosum II Acetylcholine synthesis. Am J Physiol1988; 254:H468–72.
34.
DailWGHamillRW. Parasympathetic nerves in penile erectile tissue of the rat contain choline acetyltransferase. Brain Res1989; 487:165–70.
35.
HatzimouratidisKHatzichristouDG. Looking to the future for erectile dysfunction therapies. Drugs2008; 68:231–8.
36.
HalliwellBGutteridgeJM. Free radical in biology and medicine. Oxford, UK: Oxford University Press1999.
37.
PinhoRAAndradesMEOliveiraMR. Imbalance in SOD/CAT activities in rat skeletal muscles submitted to treadmill training exercise. Cell Biol Int2006; 30:848–53.
